Winckler to Step Down as FDLI President and CEO; Recruitment Underway

WASHINGTON, March 10, 2014 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute, the premier educational organization in the field of food and drug law, announced today that President and Chief Executive Officer Susan C. Winckler will step down from that position effective May 23, 2014.

"Susan has done a superlative job leading FDLI in its mission to provide a forum and context for thoughtful and important discussion of food and drug law, and we are sorry to see her leave," said Philip Katz, Chair of the FDLI Board of Directors. "For more than four years, she has worked hard and well with the food and drug law community, Institute staff, and the Board to further FDLI's goals.  We have benefitted greatly from her experience and vision, and we wish her well in her new role."

"I have been honored to work with the Board of Directors, the Institute staff and our extraordinary members," noted Winckler. "I look forward to continuing my involvement in FDLI activities as a member."

FDLI is accepting applications for the position of President and Chief Executive Officer, who is responsible for developing and managing FDLI's programs, publications, and other services. The leader of FDLI plays a key role in the food and drug law community, working closely with members, assuring the financial stability of the organization, and leading, motivating and managing FDLI's staff. Additional information about the search may be found (http://www.fdli.org/about/careers).

Founded in 1949, FDLI is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction.  FDLI's scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

For more information about FDLI, visit www.fdli.org.

SOURCE Food and Drug Law Institute